Zero Order and Area under Curve Spectrophotometric Methods for Determination of Domperidone in Pharmaceutical Formulation

 

Audumbar Digambar Mali1*, Ritesh Bathe1, Ashpak Tamboli2

1Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade, Sangola-413307, Solapur,

Maharashtra, India.

2Department of Pharmaceutical Chemistry, Sahyadri College of Pharmacy, Methwade, Sangola-413307,

Solapur, Maharashtra, India.

*Corresponding Author E-mail: maliaudu442@gmail.com

 

ABSTRACT:

Simple, fast and reliable spectrophotometry methods were developed for determination of Domperidonein bulk and pharmaceutical dosage forms. The solutions of standard and the sample were prepared in Methanol.The quantitative determination of the drug was carried out using the zero order derivative values measured at286nm and the area under the curve method values measured at 279-293 nm. Calibration graphs constructed at their wavelengths of determination were linear in the concentration range of Domperidone using 5-25μg/ml (r²=0.999 and r²=0.998) for zero order and area under the curve spectrophotometric method. All the proposed methods have been extensively validated as per ICH guidelines. There was no significant difference between the performance of the proposed methods regarding the mean values and standard deviations. Developed spectrophotometric methods in this study are simple, accurate, precise and sensitive to assay of Domperidonein tablets.

 

KEY WORDS: Domperidone, UV visible spectrophotometry, AUC, Method Validation, Precission, Accuracy.

 

 


1. INTRODUCTION:

Domperidone is chemically known as 5-Chloro-1-[1-[3-(2-oxo-2, 3-dihydro-1H benzimidazol-1-yl)propyl]-4-piperidyl]-1,3-dihydro-2H-benzimidazol-2-one.1,2 Domperidone is an Antiemetic drug used to treat nausea and vomiting and to stimulate lactation in women. It is used in the inhibition of receptive relaxation, causes enhancement of coordinated antral-duodenal motility and results acceleration of transit in the small intestine.3,4

 

It stimulates gastro-intestinal motility and is used as an antiemetic for the short term treatment of nausea and vomiting of various aetiologies, including that associated with cancer therapy and with levodopa or bromocriptine therapy for Parkinsonism.5,6 It is an official drug in IP and BP.

 

Literature survey revealed several analytical methods UV spectrophotometry7,8 and HPLC 9 have been reported in bulk, pharmaceutical dosage form for determination of Domperidone. To our notice, so far no UV- spectrophotometry method using Zero Order and Area under Curve (AUC) has been reported for the determination of Domperidonein bulk and tablets. Hence an attempt has been made to develop new Zero Order and Area under Curve Spectrophotometric methodsmethod for estimation of Domperidonein bulk and pharmaceutical formulations with good accuracy simplicity, precision and economy.

 

Molecular formula: C22H24ClN5O2

Molecular weight: 425.911 g/mol

 

Fig.1:- The structural formula of Domperidone.

 

2. MATERIALS AND METHODS:-

2.1. Apparatus and instrumentation

A Shimadzu 1800 UV/VIS double beam spectrophotometer with 1cm matched quartz cells was used for all spectral measurements. Single Pan Electronic balance (Contech, CA 223, India) was used for weighing purpose. Sonication  of  the  solutions  was  carried  out  using  an  Ultrasonic  Cleaning  Bath  (Spectra  lab UCB  40,  India).  Calibrated volumetric glassware (Borosil®) was used for the validation study.

 

2.2. Materials

Reference standard of Domperidone API was supplied as gift sample Zydas Cadila Health Care (Ahmedabad, India).Tablet sample with label claim 10 mg per tablet were purchased from local market Solapur.

 

2.3. Method development

2.3.1. Preparation of Standard and Sample Solutions

Stock solution of 10μg/ml of Domperidone was prepared in Methanol for zero order and area under the curve spectrophotometric analysis. The standard solutions were prepared by dilution of the stock solution with Methanol in a concentration range of 5,10,15,20 and 25μg/ml with Methanol. Methanol was used as a blank solution.


 

Fig. 2: - Zero order derivative spectrum of Domperidone in Methanol (20µg/ml).

 

Fig. 3: - UV AUC spectrum of Domperidone in Methanol (20µg/ml).


2.3.2. Area under curve (Area calculation)

Area  under  curve  method  involves  the  calculation  of  integrated  value  of  absorbance  with respect to the wavelength between two selected wavelengths such as λ1 and λ2 representing start and end point of curve region. The area under curve between λ1 and λ2 was calculated using UV probe software. In this study area was integrated between wavelength ranges from 279-293nm.

Area calculation: (α+β) =

 

Where, α is area of portion bounded by curve data and a straight line connecting the start and end point, β is the area of portion bounded by a straight line connecting the start and end point on curve data and horizontal axis, λ1 and λ2 are wavelength range start and end point of curve region. 10-12

 

2.3.3. Assay Procedure

Twenty tablets each containing 10 mg of Domperidone were weighed crushed to powder and average weight was calculated. Powder equivalent to 10 mg of Domperidone was transferred in 100 ml of volumetric flask. A 50 ml of Methanol was added and sonicated for 15 minutes. Then solution was further diluted up to the mark with Methanol. The solution was filtered using Whatmann filter paper no. 41; first 5 ml of filtrate was discarded. This solution was further diluted to obtain 15µg/ml solution with water subjected for UV analysis using Methanolas blank. Appropriate dilutions were made with Methanol from stock solution for both zero order and area under the curve spectrophotometric methods.


 

 

Table 1: Assay of tablet dosage form

Sr.

No.

Sample Solution Concentration (µg/ml)

Amount found (%)* Zero order derivative

Amount found (%)* AUC

Mean % Found zero order derivative

Mean %

Found AUC

%RSD zero order derivative

%RSD

AUC

1

15

99.87

100.06

 

 

 

 

2

15

102.14

100.19

100.04

100.47

0.7813

0.9075

3

15

98.13

101.17

 

 

 

 

*n=3, % RSD = % Relative Standard Deviation.

 

Fig. 4: - Zero order derivative spectrum of Domperidone in Methanol (25µg/ml).

 

Fig. 5: -UV AUC spectrum of Domperidone in Methanol (25µg/ml).


3. RESULTS AND DISCUSSION

The zero order and area under the curve spectra for Domperidone were recorded at the wavelength of 286nm and 279-293 nm respectively.

 

3.1. Linearity and Range

Under the experimental conditions described, the graph obtained for zero order and area under the curve spectra showed linear relationship. Regression analysis was made for the slope, intercept and correlation coefficient values. The regression equations of calibration curves were y=0.023x+0.007(r2=0.999) at 286 nm for zero order derivative spectrophotometry and y=0.024x+0.014 (r2=0.998) at 279-293 nm for area under the curve spectrophotometry. The range was found to be 5-25μg/ml for both zero order and area under the curve spectrophotometric methods.

 

Fig.6: - Linearity of Domperidone by Absorbance

Fig.7: - Linearity of Domperidone by AUC.

 

Table 2: Statistical data for the calibration graphs for determination of Domperidone by Proposed methods.

Parameters

Zero order derivative

Area Under the Curve

Linearity range (µg/ml)*

5-25

5-25

r2

0.999

0.998

 

3.2. Accuracy

To study the accuracy of the proposed methods and to check the interference from excipients used in the dosage forms, recovery experiments were carried out by the standard addition method. The accuracy for the analytical method was evaluated at 80%, 100% and 120% levels of 15µg/ml standard solution. For Area under curve (AUC) was measured in wavelength range 279-293 nm and for zero order derivative at 286nm and results were obtained in terms of percent recovery. Three determinations at each level were performed and % RSD was calculated for each level.13-15


 

Fig. 8: - Zero order derivative overlay of Domperidone at diff. Concentration.


 

Table 3: Accuracy results for Domperidone

Accuracy level

Sample conc (µg/)

Std. conc

Total amnt. Added (µg/m)

%Recovery zero derivatie

% Recovery AUC*

Mean of Zero derivative*

Mean of AUC derivative*

% RSD Zero derivative

% RSD AUC

80

15

12

27

102.19

99.52

 

 

 

 

100

15

15

30

99.87

102.28

100.19

100.92

0.972

1.672

120

15

18

33

98.53

100.98

 

 

 

 

*n=3, % RSD = % Relative Standard Deviation.

 

Table 4: Results of Intra and Inter Day Precision

Parameters

Intra Day Precision

Inter Day Precision

S.D*

% RSD*

S.D*

% RSD*

Zero derivative

0.72

0.8097

0.0587

0.7148

Area under the curve

0.8219

0.7388

0.9814

1.6780

 

Table 5: Summary of validation parameters

Parameter

Zero derivative

AUC

λ range

200-400 nm

200-400 nm

Regression Equation (y=mx+c)

Y=0.023x+0.007

Y=0.024x+0.014

Measured wavelength

286nm

279-293nm

Linearity range

5-25µg/ml

5-25µg/ml

Slope

0.023

0.024

Intercept

0.007

0.014

Correlation coefficient (R2)

0.999

0.998

Limit of Detection (LOD) µg/ml

0.6479

0.9349

Limit of Quantitation (LOQ) µg/ml

1.9442

2.8051

Accuracy (Mean % Recovery)

100.19

100.92

Precission (%RSD)

0.972

1.672

 


3.3. Precision

To determine the precision of the method, Domperidone solutions at a concentration of 10μg/ml were analysed each three times for both zero order and area under the curve spectrophotometric methods. Solutions for the standard curves were prepared fresh everyday.13-15 (Table-4).

 

3.4. Sensitivity

The limit of detection (LOD) and limit of quantification (LOQ) were calculated by using the equations LOD = 3xσ/ S and LOQ = 10xσ/S, where σ is the standard deviation of intercept, S is the slope. The LOD and LOQ were found to be 0.6479μg/ml and 1.9442μg/ml respectively for zero order derivative and The LOD and LOQ were found to be 0.9349µg/ml and 2.8051µg/ml for area under the curve methods respectively. 13, 14, 15

 

3.4.5. Analysis of the Marketed Formulation

There was no interference from the excipients commonly present in the tablets. The drug content was found to be 99.07% and 101.28%zero order and area under the curve spectrophotometric methods respectively. It may therefore be inferred that degradation of Domperidone had not occurred in the marketed formulations that were analysed by this method. The low % R.S.D. value indicated the suitability of this method for routine analysis of Domperidonein pharmaceutical dosage form.

 

 

4. CONCLUSION:

No UV or Area under Curve spectrophotometric methods have been described for the determination of Domperidone. Therefore simple, fast and reliable derivative spectrophotometric methods were developed for the routine determination of Domperidone. The developed methods can be concluded as accurate, sensitive and precise and can be easily applied to the pharmaceutical formulation.

 

5. ACKNOWLEDGEMENT:

Authors were thankful to by Zydas Cadila Health Care (Ahmedabad, India) for providing gift sample of Domperidone. We would also like to thanks Principal and Management of Sahyadri College of Pharmacy, Methwade, Sangola, Solapur, Maharashtra, India for providing all the facilities to complete this work successfully.

 

6. REFERENCES:

1         Patel A.H., Patel J.K., Patel K.N., Rajput G.C., Rajgor N.B. Development and validation of derivative spectrophotometric method for simultaneous estimation of domperidone and rabeprazole sodium in bulk and dosage forms. International Journal on Pharmaceutical and Biological Research. 1; 2010: 1-5.

2         Swagati A. Moon, Subhash G. Chate, Bhanudas S. Kuchekar, Shrikant A. Karande Patil, Sonali L. Patil, Bharat D. Pagare. Spectrophotometric simultaneous determination of lafutidine and domperidone in combined tablet dosage form by absorbance corrected method and first order derivative method. Der Pharma Chemica. 4; 2012: 930-934.

 

 

3         Amr L. Saber and Alaa S. Amin. Utility of ion-pair and charge transfer complexation for spectrophotometric determination of domperidone and doxycycline in bulk and pharmaceutical formulations. Journal of analytical and bioanalytical techniques.1; 2011: 1-6.

4         Akkamma Hg, Sai Kumar S, Chandanam Sreedhar, Sreenivasa Rao T, Sukanya Kanagala, Manogna K. Development and validation of new analytical method for simultaneous estimation of domperidone and rabeprazole in pharmaceutical dosage forms.Research Journal of Pharmaceutical, Biological and Chemical Sciences. 3; 2012: 705-712.

5         Shozan M, Chaudhari BG, Patel NM, Shah PB. Development and validation of Rp-hplc method for the simultaneous estimation of domperidone and naproxen in tablet dosage form. J AOAC Int. 90; 2008: 1242-9.

6         V. Krishnaiah and Y. V. Rami Reddy. Development and validation of hplc method for simultaneous determination of omeprazole and domperidone. Der Pharma Chemica. 4; 2012: 455-459.

7         Sohan S. Chitlange, Amir I. Mulla, Ganesh R. Pawbake and Sagar B. Wankhede. A validated Rp-hplc method for simultaneous estimation of dexrabeprazole and domperidone in pharmaceutical dosage form. Der Pharmacia Sinica. 1;2010: 42-47.

8         Kalra Kapil, Naik S, Jarmal Garimaand Mishra N. Spectrophotometric method for simultaneous estimation of paracetamol and domperidone in tablet formulation. Asian J. Research Chem. 2; 2009: 112-114.

9         Dilip G Maheshwariand Priti D Trivedi. Simultaneous estimation of esomeprazole and domperidone in combined dosage form by Hplc. International Journal of Applied Science and Engineering. 9; 2011: 187-194.

10      International  Conference  on  Harmonization (ICH)  of  Technical  Requirements  for  the registration  of  Pharmaceuticals  for  Human  use,  Validation  of  Analytical  Procedures Methodology. ICH-Q2 (R1). Geneva, 1996: 1-8.

11      Mali Audumbar Digambar, Jadhav Santosh, Tamboli Ashpak, and Kargane Vijay. Development and validation of uv spectrophotometric estimation of lisinopril dihydrate in bulk and tablet dosage form using area under curve method. World Journal of Pharmacy and Pharmaceutical Sciences. 4; 2014 589-596.

12      Mali Audumbar, Nagargoje Rajendra, Hake Gorakhnath, Tamboli Ashpak. Zero Order and Area under Curve Spectrophotometric Methods for Determination of Carvedilol in Pharmaceutical Formulation. Inventi Rapid: Pharm Analysis and Quality Assurance. 2; 2015; 2:1-5.

13      Máximo Gallignani, Rebecaa.Rondón, Joséf. Ovalles, María R.Brunetto. Transmission FTIR derivative spectroscopy for estimation of furosemide in raw material and tablet dosage form. Acta Pharmaceutica Sinica B. 4; 2014: 376–383.

14      Saurabh B. Ganorkar, Atul A. Shirkhedkar. Novel Hptlc and uv-auc analyses: for simple, economical, and rapid determination of zileuton racemate. Arabian Journal of Chemistry. 2013:  Article in Press.

15      Danica A, Novovic D, Katarina Kr, Valentina M. Densitometric determination of omeprazole, pantoprazole and their impurities in pharmaceuticals. Journal of planar chromatography. 17; 2004: 169-172.

 

 

 

 

Received on 15.06.2015          Accepted on 20.07.2015        

© Asian Pharma Press All Right Reserved

Asian J. Pharm. Tech.  2015; Vol. 5: Issue 3, July- Sept. Pg 182-187

DOI: 10.5958/2231-5713.2015.00026.4